Track the Alligator Bioscience AB stock price and the full insider trade history of the company, a listed issuer based in Finland. Shares are quoted on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Alligator Bioscience AB has published 9 insider filings. Market capitalisation: €31.7m. The latest transaction was filed on 24 December 2025 (Purchase). Among the most active insiders: Peter Ostler. All data is free.
9
Insider Decl.
n/a
Thresholds
€52,713
3 ops.
Buy Volume
n/a
1 ops.
Sell Volume
33Σ signal
Buys €52,713n/a Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Alligator Bioscience AB es una empresa biofarmacéutica centrada en el desarrollo de terapias inmuno-oncológicas. Cotiza en la Bolsa de Estocolmo (XSTO).